1-3 of 3
Manish Shah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P021: Countering adenosine (ADO) in rectal cancer to improve RT responses to immune checkpoint blockade: a trial to test the safety and efficacy of PD1 (AB122) and ADO dual receptor (AB928) antagonists with chemotherapy after short-course RT

Encouse Golden, Sandra Demaria, Nir Ben Chetrit, Mehraneh Dorna Jafari, Manish Shah, Silvia Formenti
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (2_Supplement): P021.
https://doi.org/10.1158/1557-3265.TARGETEDTHERAP-P021
Published: 26 January 2025
View article titled, Abstract P021: Countering adenosine (ADO) in rectal cancer to improve RT responses to immune checkpoint blockade: a trial to test the safety and efficacy of PD1 (AB122) and ADO dual receptor (AB928) antagonists with chemotherapy after short-course RT
Journal Articles

Evaluation of the feasibility of expression microarray analysis in endoscopically obtained biopsies of gastric carcinoma and their clinical applicability

Minaxi Jhawer, Li-Xuan Qin, Hans Gerdes, David Klimstra, Mark Schattner, Agnes Viale, David Kelsen, Manish Shah
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19_Supplement): A48.
Published: 15 August 2014
View article titled, Evaluation of the feasibility of expression microarray analysis in endoscopically obtained biopsies of gastric carcinoma and their clinical applicability
Journal Articles

A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors

Archie N. Tse, David S. Klimstra, Mithat Gonen, Manish Shah, Tahir Sheikh, Rachel Sikorski, Richard Carvajal, Janet Mui, Caroll Tipian, Eileen O'Reilly, Ki Chung, Robert Maki, Robert Lefkowitz, Karen Brown, Katia Manova-Todorova, Nian Wu, Merrill J. Egorin, David Kelsen, Gary K. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6704–6711.
https://doi.org/10.1158/1078-0432.CCR-08-1006
Published: 16 October 2008
View article titled, A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors
Open the PDF for A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors in another window
Includes: Supplementary data